ADAMTS13 and laryngotracheoesophageal cleft: Some previous studies reported that interferon and direct acting antivirals (DAAs) helped in recovery from the imbalance between ADAMTS13 enzyme and VWF substrate and high Et levels in patients with LC and hepatitis C [8,49,50].